CN105816962A - Diabetes treatment apparatus and light source material used by same - Google Patents
Diabetes treatment apparatus and light source material used by same Download PDFInfo
- Publication number
- CN105816962A CN105816962A CN201610389569.0A CN201610389569A CN105816962A CN 105816962 A CN105816962 A CN 105816962A CN 201610389569 A CN201610389569 A CN 201610389569A CN 105816962 A CN105816962 A CN 105816962A
- Authority
- CN
- China
- Prior art keywords
- light source
- fluorophor
- diabetes
- source material
- base portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title claims abstract description 28
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 26
- 239000000126 substance Substances 0.000 claims abstract description 9
- 238000000295 emission spectrum Methods 0.000 claims description 12
- 239000011575 calcium Substances 0.000 claims description 7
- 230000033001 locomotion Effects 0.000 claims description 7
- 239000011777 magnesium Substances 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- 229910052684 Cerium Inorganic materials 0.000 claims description 3
- 229910052692 Dysprosium Inorganic materials 0.000 claims description 3
- 229910052691 Erbium Inorganic materials 0.000 claims description 3
- 229910052689 Holmium Inorganic materials 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 229910052779 Neodymium Inorganic materials 0.000 claims description 3
- 229910052777 Praseodymium Inorganic materials 0.000 claims description 3
- 229910052772 Samarium Inorganic materials 0.000 claims description 3
- 229910052769 Ytterbium Inorganic materials 0.000 claims description 3
- 229910052788 barium Inorganic materials 0.000 claims description 3
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims description 3
- 229910052797 bismuth Inorganic materials 0.000 claims description 3
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000006073 displacement reaction Methods 0.000 claims description 3
- KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical compound [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 claims description 3
- UYAHIZSMUZPPFV-UHFFFAOYSA-N erbium Chemical compound [Er] UYAHIZSMUZPPFV-UHFFFAOYSA-N 0.000 claims description 3
- KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium atom Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 claims description 3
- OHSVLFRHMCKCQY-UHFFFAOYSA-N lutetium atom Chemical compound [Lu] OHSVLFRHMCKCQY-UHFFFAOYSA-N 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 claims description 3
- PUDIUYLPXJFUGB-UHFFFAOYSA-N praseodymium atom Chemical compound [Pr] PUDIUYLPXJFUGB-UHFFFAOYSA-N 0.000 claims description 3
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 claims description 3
- 229910052706 scandium Inorganic materials 0.000 claims description 3
- SIXSYDAISGFNSX-UHFFFAOYSA-N scandium atom Chemical compound [Sc] SIXSYDAISGFNSX-UHFFFAOYSA-N 0.000 claims description 3
- 229910052712 strontium Inorganic materials 0.000 claims description 3
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims description 3
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052727 yttrium Inorganic materials 0.000 claims description 3
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 1
- 239000005297 pyrex Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 210000000496 pancreas Anatomy 0.000 abstract description 5
- 239000000843 powder Substances 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000007547 defect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 206010018473 Glycosuria Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/54—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing zinc or cadmium
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/55—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing beryllium, magnesium, alkali metals or alkaline earth metals
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/70—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing phosphorus
- C09K11/71—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing phosphorus also containing alkaline earth metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0632—Constructional aspects of the apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0642—Irradiating part of the body at a certain distance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0656—Chemical light sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
Abstract
The invention relates to the technical field of medical treatment, in particular to a diabetes treatment apparatus and a light source material used by the same. The light source material includes fluorescent powder, wherein the fluorescent powder is prepared from, by mass, 0.1-100.0 parts of ultraviolet light fluorescence body and 0.0-99.9 parts of visible light fluorescence body, the ultraviolet light fluorescence body is composed of a fluorescence body A or a fluorescence body B or a combination of the fluorescence body A and the fluorescence body B, a chemical expression of the fluorescence body A is M1-x-y-Al 16O27: CdxRy, and a chemical expression of the fluorescence body B is Ca3-x(PO4) 2 Cex. A fluorescent light source having the advantages of high luminous efficiency, small lumens depreciation, good chemical stability and the like by integrating ultraviolet light and visible light, can adopt a light irradiation mode and utilize the principles of biomedicine and photonics to irradiate the trunk and pancreas parts of a diabetes patient, and due to the fact that the whole light source material can emit visible light, defocus laser and healthy waveforms of a UV-B band, the diabetes and relevant diseases caused by the diabetes can be effectively prevented and treated.
Description
Technical field
The present invention relates to field of medical technology, a kind of diabetes curing instrument and the light source used thereof
Material.
Background technology
Diabetes are the metabolic diseases of a kind of multi-pathogenesis, are characterized in chronic hyperglycemia, divide with because of insulin
The carbohydrate of secreting defect or effect defect and cause, fat, the metabolism disorder such as protein.At present,
For the treatment of diabetes, market occurring in that various diabetes curing instrument, these therapeutic instruments mostly pass through
Output of laser, infrared ray, magnetic line of force isopulse physical wave stimulate the particular acupoint of human body to reach treatment
The purpose of diabetes, but due to the design defect in terms of structure and details, the treatment effect of these therapeutic instruments
Effective percentage the most poor, treatment is relatively low, it is impossible in the purpose truly playing treatment.
Therefore, how existing therapeutic instrument and correlation technique thereof improvement project are proposed, in being current industry
Technical problem urgently to be resolved hurrily.
Summary of the invention
The deficiency existed for above-mentioned prior art, one of them purpose of the present invention is that a kind of utilization is raw
Diabetes are effectively prevented by thing medical science and photonic propulsion principle and the diabetes curing instrument treated used
Source material；Further object is that offer is a kind of simple and compact for structure, with above-mentioned light source material
Based on material, can effectively prevent, treat diabetes and the diabetes curing instrument of relevant disease caused thereof.
To achieve these goals, the present invention adopts the following technical scheme that
A kind of source material, it includes fluorescent material, and by mass percentage, described fluorescent material is by 0.1-100.0
Ultraviolet light fluorophor and 0.0-99.9 visible fluorescence body constitute, wherein, described ultraviolet light fluorophor
It is made up of A fluorophor or is made up of B fluorophor or combined by A fluorophor and B fluorophor；
The chemical expression of described A fluorophor is M1-x-y·Al16O27: CdxRy, the chemistry of described B fluorophor
Expression formula is Ca3-x(PO4)2·Cex；Wherein, 0.001≤x≤0.1,0.001≤y≤0.5, M be calcium,
A kind of element in barium, strontium, magnesium, zinc or the combination of multiple element, R be bismuth, scandium, yttrium, praseodymium, samarium,
A kind of element in cerium, dysprosium, holmium, neodymium, erbium, ytterbium, lutecium or the combination of multiple element.
Preferably, described A fluorophor peak of emission spectrum under the exciting of the ultraviolet light that wavelength is 254nm
Value scope is 305 ± 5nm.
Preferably, described B fluorophor peak of emission spectrum under the exciting of the ultraviolet light that wavelength is 254nm
Value scope is 350nm to 365 ± 5nm.
A kind of diabetes curing instrument, it includes body, described body is equiped with a bed body, described body
Go up, be positioned at least one quantum generator that is provided above of bed body, described body is also associated with one
Penetrating the peak ranges of the spectrum mobile module between 297-450nm, described quantum generator includes auxiliary
Light source and fluorescence light source, the source material of described fluorescence light source uses above-mentioned a kind of source material, described
Secondary light source is defocused laser and LED.
Preferably, the peak wavelength of described defocused laser is 808nm, and the peak wavelength of described LED is
The emission spectrum of secondary light source described in 305nm to 460nm is in the range of 302nm-808nm.
Preferably, described fluorescence light source also includes that profile is Straight, elbow-shaped, spheroidal or elliposoidal
Lamp housing, described lamp housing is made up of high-boron-silicon glass.
Preferably, described body includes base portion and is arranged in the overhead guard portion above base portion, described base
Portion is connected as a single entity with overhead guard portion by least two support arms, and described bed body is installed in the upper surface of base portion,
Described quantum generator is installed in the lower surface in overhead guard portion.
Preferably, also it is equiped with in described base portion for driving bed body to make vertical lift relative to base portion
First drive assembly of motion, described first drive assembly includes first rotating arm, the second turning arm and liquid
Pressure driver, the middle part of described first rotating arm is hinged mutually with the middle part of the second turning arm, and described hydraulic pressure drives
The fixing end of dynamic device is installed in the root of first rotating arm, power end is connected to the middle part of the second turning arm also
Being positioned at the top in hinge region, the root of described first rotating arm is pivotally connected with base portion simultaneously, described
The root of the second turning arm is connected in base portion by railroad, the top of described first rotating arm with
The top of the second turning arm is connected with bed body simultaneously.
Preferably, also it is equiped with in described overhead guard portion and makees water for drive volume electronic generator relative to overhead guard portion
Second drive assembly of flat feed motion, described second drive assembly includes parallel being installed in of at least two
Leading truck in overhead guard portion and at least one slide bar driver, described quantum generator is set up in two guiding
Between frame, described slide bar driver drives quantum generator moves along leading truck as horizontal feed.
Owing to have employed such scheme, the present invention, by being integrally combined with visible ray by ultraviolet light, can be formed
Having the fluorescence light source of the features such as luminous efficiency is high, light decay is little, chemical stability is good, fluorescence light source can be adopted
The mode using up irradiation the principle utilizing biomedicine and photonic propulsion are to the trunk of diabetics and pancreas
Part is irradiated, and the fluorescence light source owing to being formed based on this source material can be launched visible ray, dissipate
Burnt laser and the healthy waveform of UV-B section；The light quantity that the therapeutic instrument formed based on this fluorescence light source is discharged
Son can promote the human body metabolism to blood glucose, and simultaneously under the exciting of light quantum, tissue absorbs energy
Electronics generation transition also gives off energy, and promotes the ion concentration gradient balance of cell, corrects metabolic function
Disorderly, it is thus possible to effectively prevention, treatment diabetes and the relevant disease caused therefrom, it has knot
Structure is the compactest, easy to use, therapeutic effect outstanding feature.
Accompanying drawing explanation
Fig. 1 is the overall structure schematic diagram () of the embodiment of the present invention；
Fig. 2 is the overall structure schematic diagram (two) of the embodiment of the present invention；
Fig. 3 is the STRUCTURE DECOMPOSITION schematic diagram of the embodiment of the present invention.
Detailed description of the invention
Below in conjunction with accompanying drawing, embodiments of the invention are described in detail, but the present invention can be by right
Require that the multitude of different ways limiting and covering is implemented.
A kind of fluorescence light source of the embodiment of the present invention, it includes fluorescent material, by mass percentage, fluorescent material
It is made up of the ultraviolet light fluorophor of 0.1-100.0 and the visible fluorescence body of 0.0-99.9；Wherein, ultraviolet
Light fluorophor is made up of A fluorophor or is made up of B fluorophor or by A fluorophor and the combination of B fluorophor
Become；The chemical expression of A fluorophor is M1-x-y·Al16O27: CdxRy, the chemical expression of B fluorophor is
Ca3-x(PO4)2·Cex；Wherein, 0.001≤x≤0.1,0.001≤y≤0.5, M be calcium (Ca), barium (Ba),
A kind of element in strontium (Sr), magnesium (Mg), zinc (Zn) or the combination of multiple element, R be bismuth (Bi),
Scandium (Sc), yttrium (Y), praseodymium (Pr), samarium (Sm), cerium (Ce), dysprosium (Dy), holmium (Ho), neodymium (Nd), erbium
(Er), a kind of element in ytterbium (Yb), lutecium (Lu) or the combination of multiple element.
Thus, by will the component of ultraviolet light fluorophor be improved, ultraviolet light is utilized to tie with visible ray
The form of unification body, defines one and has the features such as luminous efficiency is high, light decay is little, chemical stability is good
Source material, it can use the mode that light irradiates the principle utilizing biomedicine and photonic propulsion to glycosuria
Trunk and the pancreas part of patient are irradiated, due to source material can launch visible ray, ultraviolet dissipate
Burnt laser and the healthy waveform of UV-B section, it is thus possible to effectively prevent, treat diabetes and draw therefrom
The relevant disease sent out, to strengthening the resistivity of human body diseases and maintaining health to play vital
Effect.
For ensureing that fluorescence light source can launch effective healthy waveform, the Ultraluminescence body of the present embodiment is at ripple
Under the exciting of the ultraviolet light of a length of 254nm, the peak ranges of emission spectrum is preferably 305 ± 5nm.Meanwhile,
Visible fluorescence body peak ranges of emission spectrum under the exciting of the ultraviolet light that wavelength is 254nm is the most preferred
For 350nm to 365 ± 5nm.
Based on above-mentioned fluorescence light source, as shown in Figure 1 to Figure 3, present invention also offers a kind of diabetes to control
Treating instrument, it includes body, is equiped with a bed body 1 on body, on body, is positioned at above bed body 1
Being provided with at least one quantum generator 2, the peak ranges being also associated with an emission spectrum on body exists
(not shown in figure, it can use the hand-held mode liver to human body to mobile module between 297-450nm
Position is irradiated, and is to be realized by connecting line (such as wire or connection etc.) with the connected mode of body
), quantum generator 2 includes secondary light source (not shown) and fluorescence light source (not shown),
Wherein, the source material of fluorescence light source uses above-mentioned a kind of source material, and secondary light source is then at least
One defocused laser and LED.Thus utilize fluorescence light source and secondary light source to constitute the light source of therapeutic instrument
(i.e. quantum generator 2), after patient couches in bed body, by the quantum generator skin to diabetics
Skin and pancreas part are irradiated, the effect reaching physical therapy with this, preventing and treat.
For ensureing the light radiation response of therapeutic instrument, the peak wavelength of the defocused laser of the present embodiment is 808nm,
The peak wavelength of LED be the emission spectrum of secondary light source described in 305nm to 460nm in the range of
302nm-808nm。。
For optimize whole therapeutic instrument structure, the fluorescence light source of the present embodiment also include profile be Straight,
The lamp housing (not shown) of elbow-shaped, spheroidal or elliposoidal, lamp housing is then made up of high-boron-silicon glass,
With this, utilize high boron glass through UV-B section light and visible ray and UV-C section light to be carried out simultaneously
Cut-off, it is ensured that the light transmission of healthy waveform.
For simplifying the structure of whole therapeutic instrument to greatest extent, improve its convenience used, the present embodiment
Body include base portion 3 and be arranged in the overhead guard portion 4 above base portion 3；Wherein, base portion 3 is passed through
Article at least two, support arm 5 is connected as a single entity with overhead guard portion 4, and bed body 1 is then installed in the upper table of base portion 3
Face, quantum generator 2 is installed in the lower surface in overhead guard portion 4；Thus in overhead guard portion 4 and base portion 3 it
Between form enough spaces couched for human body；Article two, support arm 5 then can use be similar to cornerwise
Mode is arranged, to reduce the quantity of the blocking parts between overhead guard portion 4 and base portion 3 to greatest extent,
It is easy to patient and enters therapeutic instrument.
For optimizing the performance of therapeutic instrument, it is simple to utilization electronic generator 2 carries out omnibearing illumination to human body
Penetrate, be also equiped with in base portion 3 for driving bed body 1 to make vertical displacement movement relative to base portion 3
The first drive assembly, first drive assembly of the present embodiment includes first rotating arm the 6, second turning arm 7
With hydraulic unit driver 8；Wherein, the middle part of first rotating arm 6 is hinged mutually with the middle part of the second turning arm 7,
The fixing end of hydraulic unit driver 8 is installed in the root of first rotating arm 6, power end is connected to the second rotation
The middle part of arm 7 is also positioned at the top in hinge region, the root of first rotating arm 6 simultaneously with base portion 3 pivot
Turning and connect, the root of the second turning arm 7 is connected in base portion 3 by railroad 9, and simultaneously first
The top of turning arm 6 is connected with bed body 1 with the top of the second turning arm 7 simultaneously；Thus, utilize first
The structural relation being similar to X-shaped that turning arm 6 and the second turning arm 7 are formed, passes through hydraulic-driven
Device 8 controls angle change between the two, makes bed body 1 be located relatively at base portion 3 and makees vertical displacement movement,
Thus according to the distance between actually used situation adjustment amount electronic generator 2 and patient, it is ensured that light irradiate away from
From and the controllability of scope.
For improving its convenience used further, also it is equiped with in overhead guard portion 4 for driving quantum to send out
The second drive assembly of horizontal feed motion made by raw device 2 relative to overhead guard portion 4, and the second of the present embodiment drives
Dynamic assembly includes that the parallel leading truck 10 being installed in overhead guard portion 4 of at least two and at least one slide bar drive
Dynamic device 11；Wherein, quantum generator 2 is set up between two leading trucks 6, and slide bar driver 11 is then
Drive volume electronic generator 2 moves along leading truck 10 as horizontal feed；Thus quantum generator 2 can be made to carry out
Position is moved, with according to the practical situation irradiation to patient.
It addition, moving treatment module (not shown), its emission spectrum peak also can be arranged on therapeutic instrument
Value scope is preferably controlled between 300nm-570nm, has utilized it to treat pancreas part.
For ensureing that therapeutic instrument is to the prevention of relevant disease and therapeutic effect, a kind of glycosuria of the embodiment of the present invention
Disease therapeutic apparatus can use method used as described below, and the method comprises the following steps:
S1, utilize above-mentioned diabetes curing instrument, and according to the actual pathologic condition of patient determine human body with
Distance between quantum generator 2；
S2, after human body lies low in bed body 1, by predetermined distance adjust bed body 1 the highest
Degree, then opening electronic generator, human body is irradiated by utilization electronic generator and mobile module；Its
In, the light power of quantum generator is that accumulation every day is less than 10 μ w/cm2/ min～
200μw/cm2/ min, the light power of mobile module is that accumulation every day is less than 10 μ w/cm2/ min～
200μw/cm2/min。
The foregoing is only the preferred embodiments of the present invention, not thereby limit the scope of the claims of the present invention,
Every equivalent structure utilizing description of the invention and accompanying drawing content to be made or equivalence flow process conversion, or directly
Or indirectly it is used in other relevant technical fields, the most in like manner it is included in the scope of patent protection of the present invention.
Claims (9)
1. a source material, it includes fluorescent material, it is characterised in that: by mass percentage, institute
State fluorescent material to be made up of the ultraviolet light fluorophor of 0.1-100.0 and the visible fluorescence body of 0.0-99.9, its
In, described ultraviolet light fluorophor is made up of A fluorophor or is made up of B fluorophor or by A fluorophor and B
Fluorophor combines；
The chemical expression of described A fluorophor is M1-x-y·Al16O27: CdxRy, the chemistry of described B fluorophor
Expression formula is Ca3-x(PO4)2·Cex；Wherein, 0.001≤x≤0.1,0.001≤y≤0.5, M be calcium,
A kind of element in barium, strontium, magnesium, zinc or the combination of multiple element, R be bismuth, scandium, yttrium, praseodymium, samarium,
A kind of element in cerium, dysprosium, holmium, neodymium, erbium, ytterbium, lutecium or the combination of multiple element.
2. a kind of source material as claimed in claim 1, it is characterised in that: described A fluorophor
Under the exciting of the ultraviolet light that wavelength is 254nm, the peak ranges of emission spectrum is 305 ± 5nm.
3. a kind of source material as claimed in claim 1, it is characterised in that: described B fluorophor
Under the exciting of the ultraviolet light that wavelength is 254nm, the peak ranges of emission spectrum is 350nm to 365 ± 5nm.
4. a diabetes curing instrument, it includes body, it is characterised in that: install on described body
There is a bed body, on described body, be positioned at least one quantum generator that is provided above of bed body, described
The peak ranges of the emission spectrum mobile module between 297-450nm it is also associated with on body, described
Quantum generator includes secondary light source and fluorescence light source, and the source material of described fluorescence light source uses right to want
Seeking a kind of source material according to any one of 1-3, described secondary light source is defocused laser and LED.
5. a kind of diabetes curing instrument as claimed in claim 4, it is characterised in that defocus described in:
The peak wavelength of laser is 808nm, and the peak wavelength of described LED is to assist described in 305nm to 460nm
The emission spectrum of light source is in the range of 302nm-808nm.
6. a kind of diabetes curing instrument as claimed in claim 4, it is characterised in that: described fluorescence
Light source also includes that profile is the lamp housing of Straight, elbow-shaped, spheroidal or elliposoidal, and described lamp housing is by height
Pyrex are made.
7. a kind of diabetes curing instrument as according to any one of claim 4-6, it is characterised in that:
Described body includes base portion and is arranged in the overhead guard portion above base portion, and described base portion passes through at least two
Bar support arm is connected as a single entity with overhead guard portion, and described bed body is installed in the upper surface of base portion, and described quantum is sent out
Raw device is installed in the lower surface in overhead guard portion.
8. a kind of diabetes curing instrument as claimed in claim 7, it is characterised in that: described base
Also it is equiped with for driving bed body to make the first drive assembly of vertical displacement movement relative to base portion in portion,
Described first drive assembly includes first rotating arm, the second turning arm and hydraulic unit driver, described first rotation
The middle part of pivoted arm is hinged mutually with the middle part of the second turning arm, and the fixing end of described hydraulic unit driver is installed in
The root of one turning arm, power end are connected to the middle part of the second turning arm and are positioned at the top in hinge region,
The root of described first rotating arm is pivotally connected with base portion simultaneously, and the root of described second turning arm passes through
Railroad is connected in base portion, and the top of the top of described first rotating arm and the second turning arm is simultaneously
It is connected with bed body.
9. a kind of diabetes curing instrument as claimed in claim 7, it is characterised in that: described overhead guard
The second driving making horizontal feed motion for drive volume electronic generator relative to overhead guard portion also it is equiped with in portion
Assembly, described second drive assembly includes the parallel leading truck being installed in overhead guard portion of at least two and extremely
A few slide bar driver, described quantum generator is set up between two leading trucks, and described slide bar drives
Device drive volume electronic generator moves along leading truck as horizontal feed.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610389569.0A CN105816962B (en) | 2016-06-03 | 2016-06-03 | A kind of diabetes curing instrument and its source material used |
| PCT/CN2016/097275 WO2017206381A1 (en) | 2016-06-03 | 2016-08-30 | Diabetes therapeutic apparatus and light source material used thereby |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610389569.0A CN105816962B (en) | 2016-06-03 | 2016-06-03 | A kind of diabetes curing instrument and its source material used |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105816962A true CN105816962A (en) | 2016-08-03 |
| CN105816962B CN105816962B (en) | 2019-01-22 |
Family
ID=56531957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610389569.0A Active CN105816962B (en) | 2016-06-03 | 2016-06-03 | A kind of diabetes curing instrument and its source material used |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN105816962B (en) |
| WO (1) | WO2017206381A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017206381A1 (en) * | 2016-06-03 | 2017-12-07 | 长春先盈医疗科技有限公司 | Diabetes therapeutic apparatus and light source material used thereby |
| CN109568797A (en) * | 2018-11-28 | 2019-04-05 | 蔻诗弥生物科技(上海)股份有限公司 | A kind of energy of a quantum conversion load chamber |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1617293A (en) * | 2003-11-10 | 2005-05-18 | 松下电器产业株式会社 | Cold cathode fluororescent lamp and back light unit |
| CN101508894A (en) * | 2009-03-20 | 2009-08-19 | 孙德春 | Alkaline earth metal borate fluorinate, preparation and uses thereof |
| CN101882553A (en) * | 2010-06-25 | 2010-11-10 | 孙德春 | Fluorescent lamp, photodynamic cholesterol reducing instrument using fluorescent lamp as light source and using method thereof |
| CN103736207A (en) * | 2013-12-19 | 2014-04-23 | 中国人民解放军第四军医大学 | Bone injury/osteoporosis treatment bed based on multi-physical factor synergistic effect |
| US20140323946A1 (en) * | 2011-07-08 | 2014-10-30 | Duke University | Phosphors and scintillators for light stimulation within a medium |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5888424A (en) * | 1997-07-24 | 1999-03-30 | E. I. Du Pont De Nemours And Company | Fluorescent fluoroplastics |
| US20090268429A1 (en) * | 2005-11-10 | 2009-10-29 | Nozomu Hashimoto | Fluorescent lamp, manufacturing method therefor, lighting device using the fluorescent lamp, and display device |
| CN204951963U (en) * | 2015-09-02 | 2016-01-13 | 韩国栋 | Treatment bed with infrared physiotherapy equipment |
| CN105816962B (en) * | 2016-06-03 | 2019-01-22 | 孙德春 | A kind of diabetes curing instrument and its source material used |
-
2016
- 2016-06-03 CN CN201610389569.0A patent/CN105816962B/en active Active
- 2016-08-30 WO PCT/CN2016/097275 patent/WO2017206381A1/en active Application Filing
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1617293A (en) * | 2003-11-10 | 2005-05-18 | 松下电器产业株式会社 | Cold cathode fluororescent lamp and back light unit |
| CN101508894A (en) * | 2009-03-20 | 2009-08-19 | 孙德春 | Alkaline earth metal borate fluorinate, preparation and uses thereof |
| CN101882553A (en) * | 2010-06-25 | 2010-11-10 | 孙德春 | Fluorescent lamp, photodynamic cholesterol reducing instrument using fluorescent lamp as light source and using method thereof |
| US20140323946A1 (en) * | 2011-07-08 | 2014-10-30 | Duke University | Phosphors and scintillators for light stimulation within a medium |
| CN103736207A (en) * | 2013-12-19 | 2014-04-23 | 中国人民解放军第四军医大学 | Bone injury/osteoporosis treatment bed based on multi-physical factor synergistic effect |
Non-Patent Citations (1)
| Title |
|---|
| 刘应亮等: "BaMAl10O17 (M=Be ,Mg ,Ca ,Zn ,Cd ,Mn ,Co ,Li)体系的合成、结构和Eu2+在其中的发光", 《无机化学学报》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017206381A1 (en) * | 2016-06-03 | 2017-12-07 | 长春先盈医疗科技有限公司 | Diabetes therapeutic apparatus and light source material used thereby |
| CN109568797A (en) * | 2018-11-28 | 2019-04-05 | 蔻诗弥生物科技(上海)股份有限公司 | A kind of energy of a quantum conversion load chamber |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105816962B (en) | 2019-01-22 |
| WO2017206381A1 (en) | 2017-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69434525T3 (en) | Apparatus for photodynamic therapy | |
| EP2968972B1 (en) | Quantum dot light-emitting diodes for phototherapy | |
| US20040111132A1 (en) | Phototherapeutic treatment methods and apparatus | |
| RU112631U1 (en) | DEVICE OF PHOTODYNAMIC INFLUENCE ON THE FABRIC OF A LIVING ORGANISM | |
| KR20150143456A (en) | Phototherapeutic device, method and use | |
| CN1610570A (en) | Illumination radiation treatment of skin conditions | |
| EP3943151A1 (en) | Light emission device | |
| KR101598665B1 (en) | The light therapy by skin improvement and hair restore device | |
| US20050065577A1 (en) | Low level laser tissue treatment | |
| JP7336756B2 (en) | Phototherapeutic device and light emission method for phototherapeutic device | |
| CN105816962A (en) | Diabetes treatment apparatus and light source material used by same | |
| WO2016208244A1 (en) | Photodynamic therapy light irradiating device and light irradiating method | |
| CA2947392C (en) | Apparatus and method for multiwavelength photodynamic therapy | |
| CN108926779A (en) | A kind of intelligence spectrum therapy bed | |
| US20160279436A1 (en) | Phototherapy Apparatus with Dosage Control | |
| CN1867377A (en) | Apparatus for illuminating part of the body | |
| CN106085418B (en) | A kind of gout treatment instrument and its source material used | |
| Lin et al. | 3D upconversion barcodes for combinatory wireless neuromodulation in behaving animals | |
| RU2539535C1 (en) | Matrix laser emitter for physiotherapeutic apparatus | |
| JP7336757B2 (en) | Filter for phototherapy equipment | |
| CN105907394B (en) | A kind of Adjust-blood lipid instrument and its source material used | |
| KR20210107869A (en) | light irradiation device | |
| CN2675164Y (en) | Photon acne treating apparatus | |
| CN208710829U (en) | A kind of LED light power therapentic equipment | |
| US20150343232A1 (en) | Method of combined treatment of maligant tumors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200409 Address after: No. 666 super group street, Changchun hi tech Zone, Jilin, Jilin Patentee after: CHANGCHUN XIANYING MEDICAL TECHNOLOGY Co.,Ltd. Address before: No.4 Xinyi Road, Chaoyang District, Changchun City, Jilin Province Patentee before: Sun Dechun |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A diabetes therapeutic apparatus and its light source material Effective date of registration: 20220610 Granted publication date: 20190122 Pledgee: Jilin Zhongxin Technology Credit Financing Guarantee Co.,Ltd. Pledgor: CHANGCHUN XIANFULL MEDICAL TECHNOLOGY Co.,Ltd. Registration number: Y2022220000014 |